You are here

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Worth $6.3 Billion by 2024 - Exclusive Report by MarketsandMarkets™

CHICAGO, May 22, 2019 /PRNewswire/ -- According to the new market research report "Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents, Software, Services), Application (Clinical, Oncology, Forensics), End-user (Hospitals, Diagnostic Labs, Academia, Pharma-Biotech, CRO) - Global Forecast to 2024", published by MarketsandMarkets™,  the market is projected to reach USD 6.3 billion by 2024 from USD 4.1 billion in 2019, at a CAGR of 8.8%.

Don't miss out on business opportunities in Digital PCR (dPCR) and Real-time PCR (qPCR) Market

The rising incidences of target diseases (such as HIV, malaria, tuberculosis, and cancer) and genetic disorders; increasing use of biomarker profiling for disease diagnosis and monitoring; and successful completion of the Human Genome Sequencing Project are a few key factors driving the growth of this market. In addition, ongoing technological advancements in PCR technologies and support for genomic research have contributed to market growth. 

Reagents and consumables to dominate the qPCR market in 2019

Reagents and consumables are expected to account for the largest share among qPCR product categories in 2019. The large share of this segment is due to the expanding applications of qPCR (owing to its technological benefits over traditional PCR), growing private-public funding for life science research, and the rising number of probe-based multiplex genetic analysis procedures (that require the analysis of low-volume gene samples).

Browse in-depth TOC on "Digital PCR (dPCR) and Real-time PCR (qPCR) Market"

120 – Tables 
43 – Figures  
210 – Pages  

Get 10% Free Customization on this Report: 

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=174151204

Instruments to be the fastest-growing segment among dPCR products during the forecast period

The dPCR instruments segment is expected to grow at the fastest CAGR among dPCR products during the forecast period. The high growth of this segment will be driven by the procedural benefits offered by dPCR over qPCR (such as reduced throughput time, elimination of reference standards, absolute sample quantification, and high accuracy), growing demand for dPCR (particularly in forensics and drug discovery), and the rising number of dPCR-based genetic research activities across the globe.

Geographically, Asia Pacific is expected to be the fastest-growing market segment

North America accounts for the largest share of the dPCR and qPCR market. However, the Asia Pacific is expected to grow at the fastest CAGR during the forecast period. The high growth of this segment is mainly attributed to the ongoing expansion & modernization of healthcare infrastructure in emerging Asian countries, increasing number of research projects in China, India, and Japan in the fields of genomics and cancer, rising outsourcing of clinical research to Asia-based CROs by leading drug manufacturing companies, and continuous government support for genomics-based research activities in emerging Asia Pacific countries.

Inquiry Before Buying: 
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=174151204

The major players operating in the dPCR and qPCR market are Thermo Fisher Scientific, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Germany), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluidigm Corporation (US), Danaher Corporation (US), Abbott Laboratories (US), Merck KGaA (Germany), Becton Dickinson and Company (US), Promega Corporation (US), Eppendorf AG (Germany), and Analytik Jena AG (Germany).

Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting

About MarketsandMarkets™ 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/digital-pcr-market.asp 
Visit Our Website: https://www.marketsandmarkets.com    

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg